0001387131-18-004753.txt : 20180914
0001387131-18-004753.hdr.sgml : 20180914
20180914193457
ACCESSION NUMBER: 0001387131-18-004753
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180912
FILED AS OF DATE: 20180914
DATE AS OF CHANGE: 20180914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bernick Brian
CENTRAL INDEX KEY: 0001532233
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00100
FILM NUMBER: 181072191
MAIL ADDRESS:
STREET 1: 951 BROKEN SOUND PARKWAY NW
STREET 2: SUITE 320
CITY: BOCA RATON
STATE: FL
ZIP: 33487
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TherapeuticsMD, Inc.
CENTRAL INDEX KEY: 0000025743
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870233535
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6800 BROKEN SOUND PARKWAY NW
STREET 2: THIRD FLOOR
CITY: BOCA RATON
STATE: FL
ZIP: 33487
BUSINESS PHONE: 561-961-1911
MAIL ADDRESS:
STREET 1: 6800 BROKEN SOUND PARKWAY NW
STREET 2: THIRD FLOOR
CITY: BOCA RATON
STATE: FL
ZIP: 33487
FORMER COMPANY:
FORMER CONFORMED NAME: AMHN, Inc.
DATE OF NAME CHANGE: 20090930
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF ENTERPRISES INC
DATE OF NAME CHANGE: 19970915
FORMER COMPANY:
FORMER CONFORMED NAME: CROFF OIL CO
DATE OF NAME CHANGE: 19920703
4
1
bernick-form4_091218.xml
OWNERSHIP DOCUMENT
X0306
4
2018-09-12
0
0000025743
TherapeuticsMD, Inc.
TXMD
0001532233
Bernick Brian
6800 BROKEN SOUND PKWY NW, THIRD FLOOR
BOCA RATON
FL
33487
1
0
0
0
Common Stock
2018-09-12
4
M
0
91400
0.1018
A
6648771
I
By BF Investment Enterprises, Ltd.
Common Stock
2018-09-12
4
S
0
91400
6.255
D
6557371
I
By BF Investment Enterprises, Ltd.
Common Stock
2018-09-13
4
M
0
91400
0.1018
A
6648771
I
By BF Investment Enterprises, Ltd.
Common Stock
2018-09-13
4
S
0
91400
6.345
D
6557371
I
By BF Investment Enterprises, Ltd.
Common Stock
242000
D
Common Stock
3000
I
By BF Management, LLC
Non-Qualified Stock Option (right to buy)
0.1018
2018-09-12
4
M
0
91400
0
D
2012-01-01
2019-01-01
Common Stock
91400
1371510
I
By BF Investment Enterprises, Ltd.
Non-Qualified Stock Option (right to buy)
0.1018
2018-09-13
4
M
0
91400
0
D
2012-01-01
2019-01-01
Common Stock
91400
1280110
I
By BF Investment Enterprises, Ltd.
The reported securities are owned by BF Investment Enterprises, Ltd. ("BF Investment"). The Reporting Person (i) holds, together with his spouse as tenants by the entirety, a 70.6% membership interest in BF Management, LLC (the "GP"), the general partner of BF Investment, (ii) holds, together
with his spouse as tenants by the entirety, a 73% limited partner interest in BF Investment, (iii) holds in the aggregate, with his spouse in their individual capacities, 3.272% limited partner interest in BF Investment, and (iv) serves as the Manager of the GP. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock that expire on or before January 1, 2019.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.34, inclusive. The Reporting Person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.43, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported securities are held by the GP. As disclosed in footnote 1 above, the Reporting Person, together with his spouse as tenants by the entirety, holds a 70.6% membership interest in the GP. The Reporting Person disclaims beneficial ownership of the reported securities held by the GP, except to the extent of his pecuniary interest therein.
/s/ Brian Bernick
2018-09-14